229 related articles for article (PubMed ID: 32868152)
1. Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.
Klijian A; Khanna AK; Reddy VS; Friedman B; Ortoleva J; Evans AS; Panwar R; Kroll S; Greenfeld CR; Chatterjee S
J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):51-58. PubMed ID: 32868152
[TBL] [Abstract][Full Text] [Related]
2. The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.
Papazisi O; Palmen M; Danser AHJ
Cardiovasc Drugs Ther; 2022 Aug; 36(4):739-748. PubMed ID: 33085026
[TBL] [Abstract][Full Text] [Related]
3. Plasma Renin Activity Increases With Cardiopulmonary Bypass and is Associated With Vasoplegia After Cardiac Surgery.
Montgomery ML; Gross CR; Lin HM; Ouyang Y; Levin MA; Corkill HE; El-Eshmawi A; Adams DH; Weiner MM
J Cardiothorac Vasc Anesth; 2023 Mar; 37(3):367-373. PubMed ID: 36509636
[TBL] [Abstract][Full Text] [Related]
4. Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.
Wieruszewski PM; Bellomo R; Busse LW; Ham KR; Zarbock A; Khanna AK; Deane AM; Ostermann M; Wunderink RG; Boldt DW; Kroll S; Greenfeld CR; Hodges T; Chow JH;
Crit Care; 2023 May; 27(1):175. PubMed ID: 37147690
[TBL] [Abstract][Full Text] [Related]
5. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
[TBL] [Abstract][Full Text] [Related]
6. Use of Angiotensin II in Severe Vasoplegia After Left Pneumonectomy Requiring Cardiopulmonary Bypass: A Renin Response Analysis.
Trethowan B; Michaud CJ; Fifer S
Crit Care Med; 2020 Oct; 48(10):e912-e915. PubMed ID: 32931196
[TBL] [Abstract][Full Text] [Related]
7. [Factors involved in the development of vasoplegia after cardiac surgery with extracorporeal circulation. A prospective observational study].
Durán Bruce M; Gomar Sancho C; Holguera JC; Muliterno Español E
Rev Esp Anestesiol Reanim; 2014 May; 61(5):246-53. PubMed ID: 24507583
[TBL] [Abstract][Full Text] [Related]
8. Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
Wieruszewski PM; Radosevich MA; Kashani KB; Daly RC; Wittwer ED
J Cardiothorac Vasc Anesth; 2019 Nov; 33(11):3080-3084. PubMed ID: 31060933
[No Abstract] [Full Text] [Related]
9. Vitamin C for Vasoplegia After Cardiopulmonary Bypass: A Case Series.
Wieruszewski PM; Nei SD; Maltais S; Schaff HV; Wittwer ED
A A Pract; 2018 Aug; 11(4):96-99. PubMed ID: 29634537
[TBL] [Abstract][Full Text] [Related]
10. Management of Vasoplegic Shock in the Cardiovascular Intensive Care Unit after Cardiac Surgery.
Suero OR; Park Y; Wieruszewski PM; Chatterjee S
Crit Care Clin; 2024 Jan; 40(1):73-88. PubMed ID: 37973358
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass.
Javorski MJ; Kerolos MM; Fareed J; Perez-Tamayo RA
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1322-1326. PubMed ID: 29730947
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients.
Chow JH; Wittwer ED; Wieruszewski PM; Khanna AK
J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1407-1414. PubMed ID: 33875258
[No Abstract] [Full Text] [Related]
13. Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome.
Evans A; McCurdy MT; Weiner M; Zaku B; Chow JH
Ann Thorac Surg; 2019 Jul; 108(1):e5-e7. PubMed ID: 30582924
[TBL] [Abstract][Full Text] [Related]
14. Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation.
Tecson KM; Lima B; Lee AY; Raza FS; Ching G; Lee CH; Felius J; Baxter RD; Still S; Collier JDG; Hall SA; Joseph SM
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773577
[TBL] [Abstract][Full Text] [Related]
15. [Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].
Gilbert M; Lema G
Rev Med Chil; 2011 Mar; 139(3):368-72. PubMed ID: 21879171
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II and Vasoplegia in Cardiac Surgery: Paradigm Changer or Costly Contender?
Chow JH; Strauss E; Mazzeffi MA
J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):59-60. PubMed ID: 32950345
[No Abstract] [Full Text] [Related]
17. A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.
Noto A; Lentini S; Versaci A; Giardina M; Risitano DC; Messina R; David A
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):588-92. PubMed ID: 19581293
[TBL] [Abstract][Full Text] [Related]
18. Commentary: Is angiotensin II a game changer for vasoplegia after cardiac surgery, or is the jury still out?
Chatterjee S
J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1415-1416. PubMed ID: 33888313
[No Abstract] [Full Text] [Related]
19. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
[TBL] [Abstract][Full Text] [Related]
20. Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series.
Shah PR; Reynolds PS; Pal N; Tang D; McCarthy H; Spiess BD
Can J Anaesth; 2018 May; 65(5):560-568. PubMed ID: 29209927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
